Dissecting the effect of targeting the epidermal growth factor receptor on TGF-β-induced-apoptosis in human hepatocellular carcinoma cells

Journal of Hepatology

Volumn 55, Issue 2, 2011, Pages 351-358

  Caja, Laia ^a   Sancho, Patricia ^a   Bertran, Esther ^a   Fabregat, Isabel ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

Apoptosis; EGF; Epidermal growth factor; Hepatocellular carcinoma; TGF beta; Transforming growth factor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN BCL 2; RAS PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SMAD PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ARTICLE; CARCINOMA CELL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENES, BCL-2; HUMANS; LIVER NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA;

EID: 79960462038     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.10.041     Document Type: Article

References (42)

1. J. Massague TGFbeta in cancer Cell 134 2008 215 230
2. Y.A. Yang, G.M. Zhang, L. Feigenbaum, and Y.E. Zhang Smad3 reduces susceptibility to hepatocarcinoma by sensitizing hepatocytes to apoptosis through downregulation of Bcl-2 Cancer Cell 9 2006 445 457 (Pubitemid 43832193)
3. S.S. Thorgeirsson, T. Teramoto, and V.M. Factor Dysregulation of apoptosis in hepatocellular carcinoma Semin Liver Dis 18 1998 115 122 (Pubitemid 28224003)
4. I. Fabregat Dysregulation of apoptosis in hepatocellular carcinoma cells World J Gastroenterol 15 2009 513 520
5. Z.Z. Dong, D.F. Yao, M. Yao, L.W. Qiu, L. Zong, and W. Wu Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma Hepatobiliary Pancreat Dis Int 7 2008 288 295 (Pubitemid 351895389)
6. J. Schnur, P. Nagy, A. Sebestyen, Z. Schaff, and S.S. Thorgeirsson Chemical hepatocarcinogenesis in transgenic mice overexpressing mature TGF beta-1 in liver Eur J Cancer 35 1999 1842 1845 (Pubitemid 29512317)
7. J. Gotzmann, H. Huber, C. Thallinger, M. Wolschek, B. Jansen, and R. Schulte-Hermann Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-beta1 and Ha-Ras: steps towards invasiveness J Cell Sci 115 2002 1189 1202 (Pubitemid 34272483)
8. F. Valdes, A.M. Alvarez, A. Locascio, S. Vega, B. Herrera, and M. Fernandez The epithelial-mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor beta in fetal rat hepatocytes Mol Cancer Res 1 2002 68 78 (Pubitemid 36330212)
9. C. Coulouarn, V.M. Factor, and S.S. Thorgeirsson Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer Hepatology 47 2008 2059 2067 (Pubitemid 351945572)
10. J.L. Mott, and G.J. Gores Piercing the armor of hepatobiliary cancer: Bcl-2 homology domain 3 (BH3) mimetics and cell death Hepatology 46 2007 906 911 (Pubitemid 47436136)
11. C. Berasain, J. Castillo, J. Prieto, and M.A. Avila New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system Liver Int 27 2007 174 185 (Pubitemid 46680720)
12. Y. Inui, S. Higashiyama, S. Kawata, S. Tamura, J. Miyagawa, and N. Taniguchi Expression of heparin-binding epidermal growth factor in human hepatocellular carcinoma Gastroenterology 107 1994 1799 1804 (Pubitemid 24357636)
13. Y.H. Chung, J.A. Kim, B.C. Song, G.C. Lee, M.S. Koh, and Y.S. Lee Expression of transforming growth factor-alpha mRNA in livers of patients with chronic viral hepatitis and hepatocellular carcinoma Cancer 89 2000 977 982
14. C. Berasain, E.R. Garcia-Trevijano, J. Castillo, E. Erroba, M. Santamaria, and D.C. Lee Novel role for amphiregulin in protection from liver injury J Biol Chem 280 2005 19012 19020 (Pubitemid 41379606)
15. C. Berasain, M.J. Perugorria, M.U. Latasa, J. Castillo, S. Goni, and M. Santamaria The epidermal growth factor receptor: a link between inflammation and liver cancer Exp Biol Med 234 2009 713 725
16. Y. Shima, K. Nakao, T. Nakashima, A. Kawakami, K. Nakata, and K. Hamasaki Activation of caspase-8 in transforming growth factor-beta-induced apoptosis of human hepatoma cells Hepatology 30 1999 1215 1222 (Pubitemid 29510860)
17. B. Herrera, A.M. Alvarez, A. Sanchez, M. Fernandez, C. Roncero, and M. Benito Reactive oxygen species (ROS) mediates the mitochondrial-dependent apoptosis induced by transforming growth factor (beta) in fetal hepatocytes FASEB J 15 2001 741 751 (Pubitemid 32245992)
18. F. Valdes, M.M. Murillo, A.M. Valverde, B. Herrera, A. Sanchez, and M. Benito Transforming growth factor-beta activates both pro-apoptotic and survival signals in fetal rat hepatocytes Exp Cell Res 292 2004 209 218 (Pubitemid 38058277)
19. M.M. Murillo, G. del Castillo, A. Sanchez, M. Fernandez, and I. Fabregat Involvement of EGF receptor and c-Src in the survival signals induced by TGF-beta1 in hepatocytes Oncogene 24 2005 4580 4587 (Pubitemid 41032621)
20. L. Caja, C. Ortiz, E. Bertran, M.M. Murillo, M.J. Miro-Obradors, and E. Palacios Differential intracellular signaling induced by TGF-beta in rat adult hepatocytes and hepatoma cells: implications in liver carcinogenesis Cell Signal 19 2007 683 694 (Pubitemid 46275361)
21. A. Sanchez, A.M. Alvarez, M. Benito, and I. Fabregat Cycloheximide prevents apoptosis, reactive oxygen species production, and glutathione depletion induced by transforming growth factor beta in fetal rat hepatocytes in primary culture Hepatology 26 1997 935 943 (Pubitemid 27413660)
22. L. Caja, P. Sancho, E. Bertran, D. Iglesias-Serret, J. Gil, and I. Fabregat Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4 Cancer Res 69 2009 7595 7602
23. P. Sancho, E. Bertran, L. Caja, I. Carmona-Cuenca, M.M. Murillo, and I. Fabregat The inhibition of the epidermal growth factor (EGF) pathway enhances TGF-beta-induced apoptosis in rat hepatoma cells through inducing oxidative stress coincident with a change in the expression pattern of the NADPH oxidases (NOX) isoforms Biochim Biophys Acta 1793 2009 253 263
24. L. Coll-Mulet, D. Iglesias-Serret, A.F. Santidrian, A.M. Cosialls, M. de Frias, and E. Castano MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells Blood 107 2006 4109 4114 (Pubitemid 43726820)
25. I. Carmona-Cuenca, C. Roncero, P. Sancho, L. Caja, N. Fausto, and M. Fernandez Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity J Hepatol 49 2008 965 976
26. B. Herrera, M. Fernandez, A.M. Alvarez, C. Roncero, M. Benito, and J. Gil Activation of caspases occurs downstream from radical oxygen species production, Bcl-xL down-regulation, and early cytochrome C release in apoptosis induced by transforming growth factor beta in rat fetal hepatocytes Hepatology 34 2001 548 556 (Pubitemid 32786646)
27. I.C. Hsu, T. Tokiwa, W. Bennett, R.A. Metcalf, J.A. Welsh, and T. Sun P53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines Carcinogenesis 14 1993 987 992 (Pubitemid 23169159)
28. H. Davies, G.R. Bignell, C. Cox, P. Stephens, S. Edkins, and S. Clegg Mutations of the BRAF gene in human cancer Nature 417 2002 949 954 (Pubitemid 34716871)
29. K. Kitisin, N. Ganesan, Y. Tang, W. Jogunoori, E.A. Volpe, and S.S. Kim Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation Oncogene 26 2007 7103 7110 (Pubitemid 350059676)
30. J.S. Lee, I.S. Chu, A. Mikaelyan, D.F. Calvisi, J. Heo, and J.K. Reddy Application of comparative functional genomics to identify best-fit mouse models to study human cancer Nat Genet 36 2004 1306 1311 (Pubitemid 39577940)
31. J.S. Lee, and S.S. Thorgeirsson Genetic profiling of human hepatocellular carcinoma Semin Liver Dis 25 2005 125 132 (Pubitemid 40781065)
32. B.C. Song, Y.H. Chung, J.A. Kim, W.B. Choi, D.D. Suh, and S.I. Pyo Transforming growth factor-beta1 as a useful serologic marker of small hepatocellular carcinoma Cancer 94 2002 175 180 (Pubitemid 34049056)
33. F. Vinals, and J. Pouyssegur Transforming growth factor beta1 (TGF-beta1) promotes endothelial cell survival during in vitro angiogenesis via an autocrine mechanism implicating TGF-alpha signaling Mol Cell Biol 21 2001 7218 7230 (Pubitemid 32953476)
34. S.E. Wang, B. Xiang, M. Guix, M.G. Olivares, J. Parker, and C.H. Chung Transforming growth factor beta engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab Mol Cell Biol 28 2008 5605 5620
35. W. Pao, T.Y. Wang, G.J. Riely, V.A. Miller, Q. Pan, and M. Ladanyi KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib PLoS Med 2 2005 e17
36. R.G. Amado, M. Wolf, M. Peeters, E. Van Cutsem, S. Siena, and D.J. Freeman Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer J Clin Oncol 26 2008 1626 1634
37. X. Lu, M. Lee, T. Tran, and T. Block High level expression of apoptosis inhibitor in hepatoma cell line expressing hepatitis B virus Int J Med Sci 2 2005 30 35 (Pubitemid 40935434)
38. M. Notarbartolo, M. Cervello, L. Giannitrapani, M. Meli, P. Poma, and L. Dusonchet Expression of IAPs and alternative splice variants in hepatocellular carcinoma tissues and cells Ann NY Acad Sci 1028 2004 289 293 (Pubitemid 40361830)
39. C. Augello, L. Caruso, M. Maggioni, M. Donadon, M. Montorsi, and R. Santambrogio Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma BMC Cancer 9 2009 125
40. L.R. Roberts, and G.J. Gores Hepatocellular carcinoma: molecular pathways and new therapeutic targets Semin Liver Dis 25 2005 212 225 (Pubitemid 40781073)
41. L. Zender, M.S. Spector, W. Xue, P. Flemming, C. Cordon-Cardo, and J. Silke Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach Cell 125 2006 1253 1267 (Pubitemid 43929093)
42. I. Fabregat, C. Roncero, and M. Fernandez Survival and apoptosis: a dysregulated balance in liver cancer Liver Int 27 2007 155 162 (Pubitemid 46680718)